Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by jojomarchon Mar 01, 2018 10:23am
75 Views
Post# 27643423

RE:RE:RE:RE:Hostile takeover

RE:RE:RE:RE:Hostile takeoverI seriously doubt RW and friends would accept a $1.00 offer . IMO TLD-1433 is safe  , the trial has treated 3 low dose , 3 high dose patients  and the study hasn't been stopped so unofficially the compound is safe and tolerable  . The doctors probably agree to this but officially we have to wait for the 90 days after  P9 gets treated  before applying for Ph2 . The doctors also know if  P1-3 are walking around with functioning bladders , a potential partner would also know this . What I'm  trying to say is there is enough unofficial data for big pharma to take an educated gamble , with milestones  ,  and participate in the future of TLT . A small  upfront payment could bring us to FDA clearance for Ph2 and another Ph1b trial . TLT would gain recognition with a big pharma partner and a SP hike . 

Cheers


Bullboard Posts